In the world of antibiotics, stewardship means using drugs carefully to preserve what still works. Antibiotic R&D is the path to new antibiotics, which will (by necessity) result in a drug company (gasp!) making money. Some say that the two are mutually exclusive. ACSH advisor Dr. David Shlaes (pictured) argues otherwise.
Proper use of antibiotics in animals, just like in humans, can slow bacterial resistance. Europe leads the way in cutting antibiotic use. Meanwhile, the United States lags behind.
Clostridium difficile (C. diff) is one of the many bacteria that inhabit our gastrointestinal tract. Normally, it is harmless. But when patients receive intensive antibiotic therapy, especially in hospitals, it can overgrow and become life-threatening. Fortunately, a new study shows it can be controlled with a common-sense approach.
Antibiotic resistance is no longer a far a distant threat of the future, rather a major obstacle
Dr. Betsy McCaughey, a former ACSH Trustee, redirects the blame game in her most recent piece, Lethal Lies About Hospital
The Center for Disease Control s (CDC) ongoing efforts to prevent and control the spread of antibacterial-resistant infections has yielded new areas of intervention. They report doctors in some